Daniel Liévano
Illustrator
From this contributor
Pooling data points to new potential treatment for spinal cord injury
By gathering raw data from multiple labs, we identified an overlooked predictor of recovery after spinal cord injury. Many more insights remain trapped in scattered data.
We found a major flaw in a scientific reagent used in thousands of neuroscience experiments — and we’re trying to fix it.
As part of that ambition, we launched a public-private partnership to systematically evaluate antibodies used to study neurological disease, and we plan to make all the data freely available.
Simply making data publicly available isn’t enough. We need to make it easy — that requires community buy-in.
I helped create a standard to make it easy to upload, analyze and compare functional MRI data. An ecosystem of tools has since grown up around it, boosting reproducibility and speeding up research.
Incentivizing data-sharing in neuroscience: How about a little customer service?
To make data truly reusable, we need to invest in data curators, who help people enter the information into repositories.
Incentivizing data-sharing in neuroscience: How about a little customer service?
Explore more from The Transmitter
Prevalence of profound autism declines with new definition
The updated, more precise definition used in a CDC study includes adaptive scores.
Prevalence of profound autism declines with new definition
The updated, more precise definition used in a CDC study includes adaptive scores.
Is it time for neuroscience to shift its focus from a computational mind to a navigating mind?
Andrea Hiott explains her navigational approach to the mind, and why now is the time to embrace seemingly paradoxical findings in neuroscience.
Is it time for neuroscience to shift its focus from a computational mind to a navigating mind?
Andrea Hiott explains her navigational approach to the mind, and why now is the time to embrace seemingly paradoxical findings in neuroscience.
Human brain organoids come of age—but still have room to grow
The U.S. government has touted organoids as an alternative to animals for studying the brain. The model has improved since its debut in 2013, but scientists are still working to overcome key limitations: immaturity, consistency and the lack of vascularization.
Human brain organoids come of age—but still have room to grow
The U.S. government has touted organoids as an alternative to animals for studying the brain. The model has improved since its debut in 2013, but scientists are still working to overcome key limitations: immaturity, consistency and the lack of vascularization.